{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T10:52:45Z","timestamp":1781520765954,"version":"3.54.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcardioanesthesia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1053\/j.jvca.2026.03.014","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T08:01:52Z","timestamp":1772870512000},"page":"2157-2162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Liberation From a Persistent Low-Dose Vasopressor Requirement in Protracted Critical Illness Using Angiotensin 2 Infusion"],"prefix":"10.1053","volume":"40","author":[{"given":"Hannah M.","family":"Brinkman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan T.","family":"Wanta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail G.","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo","family":"D\u2019Andria Ursoleo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin D.","family":"Wieruszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troy G.","family":"Seelhammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica D.","family":"Wittwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5871-5186","authenticated-orcid":false,"given":"Patrick M.","family":"Wieruszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.jvca.2026.03.014_bib0001","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1056\/NEJMc1314999","article-title":"Circulatory shock","volume":"370","author":"Vincent","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2026.03.014_bib0002","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40360-016-0063-z","article-title":"Temporal trends in the utilization of vasopressors in intensive care units: An epidemiologic study","volume":"17","author":"Thongprayoon","year":"2016","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1053\/j.jvca.2026.03.014_bib0003","article-title":"Epidemiology, risk factors and outcomes of norepinephrine use in cardiac surgery with cardiopulmonary bypass: A multicentric prospective study","volume":"42","author":"Guinot","year":"2023","journal-title":"Anaesth Crit Care Pain Med"},{"key":"10.1053\/j.jvca.2026.03.014_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2024.155004","article-title":"Early high-dose vasopressors in refractory septic shock: A cohort study","volume":"86","author":"Thompson","year":"2025","journal-title":"J Crit Care"},{"key":"10.1053\/j.jvca.2026.03.014_bib0005","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1093\/ajhp\/zxac069","article-title":"Putting midodrine on the MAP: An approach to liberation from intravenous vasopressors in vasodilatory shock","volume":"79","author":"Smith","year":"2022","journal-title":"Am J Health Syst Pharm"},{"key":"10.1053\/j.jvca.2026.03.014_bib0006","doi-asserted-by":"crossref","first-page":"e508","DOI":"10.1097\/CCM.0000000000006531","article-title":"the ongoing pursuit to reduce the burden of IV vasopressor infusions","volume":"53","author":"Wieruszewski","year":"2025","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2026.03.014_bib0007","doi-asserted-by":"crossref","first-page":"6892","DOI":"10.12998\/wjcc.v12.i36.6892","article-title":"Oral blood pressure augmenting agents for intravenous vasopressor weaning","volume":"12","author":"Robinson","year":"2024","journal-title":"World J Clin Cases"},{"key":"10.1053\/j.jvca.2026.03.014_bib0008","doi-asserted-by":"crossref","first-page":"e648","DOI":"10.1097\/CCM.0000000000003814","article-title":"Continuation of newly initiated midodrine therapy after intensive care and hospital discharge: A single-center retrospective study","volume":"47","author":"Rizvi","year":"2019","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2026.03.014_bib0009","doi-asserted-by":"crossref","first-page":"e384","DOI":"10.1097\/CCM.0000000000006519","article-title":"Adjunctive midodrine therapy for vasopressor-dependent shock in the ICU: A systematic review and meta-analysis","volume":"53","author":"Kilcommons","year":"2025","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2026.03.014_bib0010","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1186\/s13054-024-05123-7","article-title":"The renin\u2013angiotensin\u2013aldosterone-system in sepsis and its clinical modulation with exogenous angiotensin II","volume":"28","author":"Legrand","year":"2024","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2026.03.014_bib0011","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/CCM.0000000000006176","article-title":"Position paper on the reporting of norepinephrine formulations in critical care from the Society of Critical Care Medicine and European Society of Intensive Care Medicine Joint Task Force","volume":"52","author":"Wieruszewski","year":"2024","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2026.03.014_bib0012","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13054-023-04404-x","article-title":"Response to: Norepinephrine formulation for equivalent vasopressive score","volume":"27","author":"Kotani","year":"2023","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2026.03.014_bib0013","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/CCM.0000000000003092","article-title":"Outcomes in patients with vasodilatory shock and renal replacement therapy treated with intravenous angiotensin II","volume":"46","author":"Tumlin","year":"2018","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2026.03.014_bib0014","first-page":"1","article-title":"Reevaluating the lower limit of renal autoregulation: Does one size fit all?","volume":"21","author":"D\u2019Amico","year":"2025","journal-title":"Signa Vitae"},{"key":"10.1053\/j.jvca.2026.03.014_bib0015","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1213\/ANE.0000000000007779","article-title":"The renin\u2013angiotensin\u2013aldosterone system in cardiac surgery and angiotensin II therapy for vasoplegia","volume":"142","author":"Zarbock","year":"2026","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2026.03.014_bib0016","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1053\/j.jvca.2019.10.017","article-title":"Adrenergic downregulation in critical care: Molecular mechanisms and therapeutic evidence","volume":"34","author":"Belletti","year":"2020","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2026.03.014_bib0017","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/0885066609340519","article-title":"Sympathetic overstimulation during critical illness: Adverse effects of adrenergic stress","volume":"24","author":"D\u00fcnser","year":"2009","journal-title":"J Intensive Care Med"},{"key":"10.1053\/j.jvca.2026.03.014_bib0018","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1124\/mol.112.082313","article-title":"Differential phosphorylation, desensitization, and internalization of \u03b11A\u2212adrenoceptors activated by norepinephrine and oxymetazoline","volume":"83","author":"Akinaga","year":"2013","journal-title":"Mol Pharmacol"},{"key":"10.1053\/j.jvca.2026.03.014_bib0019","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1007\/s00134-010-2045-8","article-title":"Vascular hyporesponsiveness to vasopressors in septic shock: From bench to bedside","volume":"36","author":"Levy","year":"2010","journal-title":"Intensive Care Med"},{"key":"10.1053\/j.jvca.2026.03.014_bib0020","doi-asserted-by":"crossref","DOI":"10.1111\/micc.12874","article-title":"Ion channels remodeling in the regulation of vascular hyporesponsiveness during shock","volume":"31","author":"Li","year":"2024","journal-title":"Microcirculation"},{"key":"10.1053\/j.jvca.2026.03.014_bib0021","article-title":"Multimodal strategy to counteract vasodilation in septic shock","volume":"42","author":"Leone","year":"2023","journal-title":"Anaesth Crit Care Pain Med"},{"key":"10.1053\/j.jvca.2026.03.014_bib0022","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13054-022-03911-7","article-title":"Vasopressor choice and timing in vasodilatory shock","volume":"26","author":"Wieruszewski","year":"2022","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2026.03.014_bib0023","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0331304","article-title":"Early multimodal vasopressor strategy in septic shock (TRICYCLE)\u2014study protocol for a randomized controlled clinical trial","volume":"20","author":"Kalamar","year":"2025","journal-title":"PLoS One"},{"key":"10.1053\/j.jvca.2026.03.014_bib0024","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.jtcvs.2021.02.097","article-title":"Evaluating the evidence for angiotensin II for the treatment of vasoplegia in critically ill cardiothoracic surgery patients","volume":"163","author":"Chow","year":"2022","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2026.03.014_bib0025","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ccc.2023.06.002","article-title":"Management of vasoplegic shock in the cardiovascular intensive care unit after cardiac surgery","volume":"40","author":"Suero","year":"2024","journal-title":"Crit Care Clin"},{"key":"10.1053\/j.jvca.2026.03.014_bib0026","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13054-018-2102-1","article-title":"Definitions and pathophysiology of vasoplegic shock","volume":"22","author":"Lambden","year":"2018","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2026.03.014_bib0027","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.chest.2020.08.2074","article-title":"Angiotensin II infusion for shock: A multicenter study of postmarketing use","volume":"159","author":"Wieruszewski","year":"2021","journal-title":"Chest"}],"container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077026002120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077026002120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T09:55:29Z","timestamp":1781517329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053077026002120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1053077026002120"],"URL":"https:\/\/doi.org\/10.1053\/j.jvca.2026.03.014","relation":{},"ISSN":["1053-0770"],"issn-type":[{"value":"1053-0770","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liberation From a Persistent Low-Dose Vasopressor Requirement in Protracted Critical Illness Using Angiotensin 2 Infusion","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiothoracic and Vascular Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jvca.2026.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}